Keith R. Leonard, President & CEO at KYTHERA BIOPHARMACEUTICALS INC (KYTH), sold 3,656 shares at $32.55 ($120K) on 2014-08-01, disclosed to the SEC on 2014-08-04.
Scheduled sale ($120k) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.55 | 2,156 | $70K | 58.5% |
| 2 | $33.15 | 1,500 | $50K | 41.5% |
| Total | $32.80 avg | 3,656 | $120K | 100% |
| Filing → |
| ISRG | SELL | 2020-02-13 | $927K | — | Filing → |
| SNNA | BUY | 2019-02-26 | $250K | — | Filing → |
| ISRG | SELL | 2017-09-01 | $854K | — | Filing → |